The store will not work correctly when cookies are disabled.
(S)-2-Amino-3-(5-(4-(4-chlorophenoxy)phenyl)-2H-tetrazol-2-yl)propanoic acid
ID: ALA4875741
PubChem CID: 164628661
Max Phase: Preclinical
Molecular Formula: C16H14ClN5O3
Molecular Weight: 359.77
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: N[C@@H](Cn1nnc(-c2ccc(Oc3ccc(Cl)cc3)cc2)n1)C(=O)O
Standard InChI: InChI=1S/C16H14ClN5O3/c17-11-3-7-13(8-4-11)25-12-5-1-10(2-6-12)15-19-21-22(20-15)9-14(18)16(23)24/h1-8,14H,9,18H2,(H,23,24)/t14-/m0/s1
Standard InChI Key: PVRNNKZLXJIKKA-AWEZNQCLSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
29.3803 -15.0066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3792 -15.8261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0872 -16.2351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7969 -15.8256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7941 -15.0030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0854 -14.5977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6711 -16.2341 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.9638 -15.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4980 -14.5934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2458 -14.9229 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.7903 -14.3136 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.3790 -13.6073 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.5804 -13.7804 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.6033 -14.3959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0812 -13.7330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9689 -15.0079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2624 -14.5988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5534 -15.0069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5554 -15.8283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2625 -16.2337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8455 -14.5987 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
34.8942 -13.8153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3720 -13.1524 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.2294 -14.5606 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.7460 -12.9877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
7 8 1 0
9 10 2 0
10 11 1 0
11 12 1 0
12 13 2 0
13 9 1 0
5 9 1 0
11 14 1 0
14 15 1 0
8 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 8 1 0
18 21 1 0
15 22 1 0
22 23 1 0
22 24 2 0
15 25 1 6
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 359.77 | Molecular Weight (Monoisotopic): 359.0785 | AlogP: 2.20 | #Rotatable Bonds: 6 |
Polar Surface Area: 116.15 | Molecular Species: ZWITTERION | HBA: 7 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.61 | CX Basic pKa: 8.79 | CX LogP: 0.61 | CX LogD: 0.59 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.69 | Np Likeness Score: -1.30 |
References
1. Markert C, Thoma G, Srinivas H, Bollbuck B, Lüönd RM, Miltz W, Wälchli R, Wolf R, Hinrichs J, Bergsdorf C, Azzaoui K, Penno CA, Klein K, Wack N, Jäger P, Hasler F, Beerli C, Loetscher P, Dawson J, Wieczorek G, Numao S, Littlewood-Evans A, Röhn TA.. (2021) Discovery of LYS006, a Potent and Highly Selective Inhibitor of Leukotriene A4 Hydrolase., 64 (4.0): [PMID:33592148] [10.1021/acs.jmedchem.0c01955] |